United States Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2026

• Afluria Quadrivalent • Fluad • Varivax • Menactra • Proquad • Pneumovax 23 • Fluarix/FluLaval • Havrix/Twinrix/Engerix–B • M–M–R II • Adacel • Boostrix • Bexsero • Menveo • Trumenba • Shingrix • Pentacel • Recombivax HB • Rotateq • Rotarix • Pediarix/Infanrix • Heplisav–B • TDVAX

Key Topics Covered in the Report:

• The Market Size of the United States Vaccines Market with Seven Years Forecast • The Market Size of the 27 Leading Vaccines with Seven Years Forecast • Thoroughly Evaluates Market Share of the 27 Leading Vaccines in the US Vaccines Market • Provides Comprehensive Insights on the Latest Vaccines Pricing Trends and Analysis • Detailed Insights of the Regulatory Framework of the US Vaccines Market • Investigates the Key Growth Drivers and Restraints of the United States Vaccines Market • Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement